GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
AMERICAN ORIENTL BIO (AOBI) [hlAlert]

Rating:
Buy AOB
down 99.96 %

AMERICAN ORIENTL BIO (AOB) rated Buy with price target $10 by Roth Capital

Posted on: Tuesday,  Dec 30, 2008  10:25 AM ET by Roth Capital

Roth Capital rated Buy AMERICAN ORIENTL BIO (OTCBB: AOBI) on 12/30/2008, when the stock price was $3186.36. Since
then, AMERICAN ORIENTL BIO has lost 99.96% as of 08/12/2015's recent price of $1.17.
If you would have followed this Roth Capital's recommendation on AOBI, you would have lost 99.96% of your investment in 2416 days.

American Oriental Bioengineering, Inc. (AOB) is an integrated, pharmaceutical company engaged in the development, manufacture and commercialization of a range of pharmaceutical and healthcare products. The Company?s business comprises prescription pharmaceutical products, over-the-counter (OTC) pharmaceutical products and nutraceutical products. Its pharmaceutical products have been approved by the Chinese State Food and Drug Administration (SFDA). The Company sells its products primarily to hospitals, clinics, pharmacies and retail outlets at over 100,000 locations in all provinces, including rural areas and cities in China. During the year ended December 31, 2008, AOB marketed over 60 pharmaceutical products in China. On October 18, 2008, the Company acquired Nuo Hua Investment Company Limited. On October 20, 2008, the Company acquired GuangXi HuiKe Pharmaceutical Research and Development Co., Ltd.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/30/2008 10:25 AM Buy
None
3,186.36 5,010.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy